Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

S. Kohno1 K. Yamaguchi2 N. Aikawa3 Y. Sumiyama4 S. Odagiri5 N. Aoki6 Y. Niki7 S. Watanabe8 M. Furue9 T. Ito10 R. Croos-Dabrera11 and K. J. Tack11

首页> 外文期刊>Journal of Antimicrobial Chemotherapy >Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

【24h】

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

机译：利奈唑胺与万古霉素治疗日本耐甲氧西林金黄色葡萄球菌引起的感染

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objectives To compare the efficacy and safety of linezolid and vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Japan.

机译：目的比较利奈唑胺和万古霉素治疗耐甲氧西林金黄色葡萄球菌（MRSA）感染的疗效和安全性。

著录项

来源
《Journal of Antimicrobial Chemotherapy》 |2007年第6期|1361-1369|共9页
作者
S. Kohno1 K. Yamaguchi2 N. Aikawa3 Y. Sumiyama4 S. Odagiri5 N. Aoki6 Y. Niki7 S. Watanabe8 M. Furue9 T. Ito10 R. Croos-Dabrera11 and K. J. Tack11;
展开▼
作者单位

Second Department of Internal Medicine Nagasaki University Graduate School of Pharmaceutical Sciences Nagasaki Japan;

Department of Microbiology Toho University School of Medicine Tokyo Japan;

Keio University Hospital Tokyo Japan;

3rd Department of Surgery Toho University School of Medicine Tokyo Japan;

Odagiri Respiratory Clinic Kanagawa Japan;

Division of Internal Medicine Shinrakuen Hospital Niigata Japan;

Department of Clinical Infectious Diseases School of Medicine Showa University Tokyo Japan;

Department of Dermatology Teikyo University School of Medicine Tokyo Japan;

Department of Dermatology Graduate School of Medical Sciences Kyusyu University Fukuoka Japan;

Pfizer Global Research and Development Tokyo Japan;

Pfizer Global Research and Development 2800 Plymouth Road Ann Arbor MI 48105 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. [J] . Kohno S, Yamaguchi K, Aikawa N, The Journal of Antimicrobial Chemotherapy . 2007,第6期

机译：利奈唑胺与万古霉素在日本治疗由耐甲氧西林的金黄色葡萄球菌引起的感染。
2. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. [J] . Itani KM, Dryden MS, Bhattacharyya H, The American Journal of Surgery . 2010,第6期

机译：利奈唑胺和万古霉素治疗复杂的皮肤和软组织感染的功效和安全性被证明是由耐甲氧西林的金黄色葡萄球菌引起的。
3. Treatment of methicillin-resistant staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: Old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents [Staphylococcus aureus resistante a meticilina con una concentración mínima inhibitoria de 2 μg/ml para vancomicina: Agentes viejos (trimetoprim/sulfametoxazol) contra agentes nuevos (daptomicina o linezolida)] [J] . The annals of pharmacotherapy . 2012,第12期

机译：对万古霉素的最低抑菌浓度为2μg/ mL的耐甲氧西林金黄色葡萄球菌感染的治疗：旧药（甲氧苄啶/磺胺甲恶唑）与新药（达托霉素或利奈唑胺）[金黄色葡萄球菌抗药性，无浓缩菌素/微球菌抑制剂2 ml para vancomicina：Agentes viejos（trimetoprim / sulfametoxazol）对立物neuvos（daptomicina o linezolida）]
4. THE EMERGENCE OF A BAD BUG: TREATMENT, INFECTION CONTROL PUBLIC HEALTH CHALLENGES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) [C] . Jeffrey B. Bender Canadian Veterinary Medical Association Convention . 2009

机译：出现坏虫子：耐甲氧西林金黄色葡萄球菌的治疗，感染控制和公共卫生挑战（MRSA）
5. A retrospective study to evaluate the efficacy of trimethoprim/sulfamethoxazole (TMP/SMX) compared to Daptomycin or Linezolid for the treatment of infections due to methicillin-resistant Staphylococcus aureus (MRSA). [D] . Poona Murari, Aparna Lakshmi. 2012

机译：回顾性研究评估甲氧苄氨嘧啶/磺胺甲恶唑（TMP / SMX）与达托霉素或利奈唑胺相比在治疗耐甲氧西林金黄色葡萄球菌（MRSA）感染中的疗效。
6. Cost comparison of linezolid versus vancomycin for treatment of complicated skin and skin-structure infection caused by methicillin-resistant Staphylococcus aureus in Quebec [O] . Martine Pettigrew, Daniel JG Thirion, Michael Libman, 2012

机译：利奈唑胺与万古霉素治疗魁北克耐甲氧西林金黄色葡萄球菌引起的复杂皮肤和皮肤结构感染的费用比较
7. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan [O] . S. Kohno, K. Yamaguchi, N. Aikawa, 2014

机译：利奈唑胺与万古霉素治疗日本耐甲氧西林金黄色葡萄球菌感染

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅